Search Results

Displaying Results 1401-1425 of 12228 "'L'"

Jul 30, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Megan Holdings Limited of Class Action Lawsuit and Upcoming Deadlines - MGN

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Jul 30, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hub Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - HUBG

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Jul 30, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Primoris Services Corporation of Class Action Lawsuit and Upcoming Deadlines - PRIM

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Jul 30, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cogent Communications Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - CCOI

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Jul 30, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against BitGo Holdings, Inc. and Certain Officers - BTGO

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Jul 30, 2026, 09:25 ET POZITÍVNE STANOVISKO VÝBORU PRE LIEKY NA HUMÁNNE POUŽITIE PODPORUJE ŠIRŠIE POUŽÍVANIE LIEKU REPATHA® OD SPOLOČNOSTI AMGEN PRED PRVÝM INFARKTOM ALEBO MOZGOVOU PRÍHODOU

(investori)REFERENCIEMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., Commodore-Mensah, Y., Currie, M. E., Elkind, M. S. V., Fan, W., Generoso, G., Gibbs, B. B., Heard, D.

More news about: Amgen


Jul 30, 2026, 09:00 ET Embark Names Naseem Anzari as Chief Financial Officer to Lead Finance Strategy and Investment in Growth

to scale and acquire with discipline, and his leadership experience will directly strengthen Embark's finance and M&A strategy." said Embark CEO L. Felice Gorordo. "I'm proud to welcome Naseem to the Embark team and excited to build alongside him as we enter our firm's next chapter of growth."As

More news about: Embark


Jul 30, 2026, 09:00 ET Nominations Open for 14th Annual International Harrington Prize for Innovation in Medicine

2026): 2026: Jointly awarded to Arul Chinnaiyan, MD, PhD, University of Michigan Medical School, and Charles L. Sawyers, MD, Memorial Sloan Kettering Cancer Center, for their transformative discoveries that uncovered the molecular basis of prostate cancer and

More news about: Harrington Discovery Institute


Jul 30, 2026, 09:00 ET Abbott recebe aprovação da ANVISA para uso de dispositivo bioabsorvível inovador em artérias abaixo do joelho

###Referências:Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease. Ramon L. Varcoe, M.B., B.S., Ph.D., M.Med. (Clin.Epi.), Brian G. DeRubertis, M.D., Raghu Kolluri, M.D., Prakash Krishnan, M.D., David C. Metzger, M.D., Marc P.

More news about: Abbott


Jul 30, 2026, 08:43 ET Kang Haggerty Adds David L. Braverman and Litigation Team from Braverman Kaskey

PHILADELPHIA, July 30, 2026 /PRNewswire/ -- Kang Haggerty LLC announced today that David L. Braverman and core members of his litigation team have joined the firm from Braverman Kaskey, strengthening Kang Haggerty's business and commercial litigation

More news about: Kang Haggerty LLC


Jul 30, 2026, 08:30 ET Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

EGFR exon 19 deletions or exon 21 L858R substitution mutations, as detected by an FDA-approved test.in combination with carboplatin and pemetrexed for the treatment of adult patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R substitution mutations, whose

More news about: Johnson & Johnson


Jul 30, 2026, 08:30 ET LA OPINIÓN FAVORABLE DEL CHMP RESPALDA UN USO MÁS AMPLIO DE REPATHA® DE AMGEN

(inversores)REFERENCIASMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., Commodore-Mensah, Y., Currie, M. E., Elkind, M. S. V., Fan, W., Generoso, G., Gibbs, B. B., Heard, D.

More news about: Amgen


Jul 30, 2026, 08:17 ET Volition Advances Nu.Q® NETs Platform Towards Commercialization

Intensive Care. doi: 10.1186/s13613-023-01204-yMorimont, L., et al. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules. 

More news about: VolitionRx Limited


Jul 30, 2026, 08:15 ET POZYTYWNA OPINIA CHMP OTWIERA DROGĘ DO SZERSZEGO STOSOWANIA LEKU REPATHA® FIRMY AMGEN PRZED WYSTĄPIENIEM PIERWSZEGO ZAWAŁU SERCA LUB UDARU MÓZGU

(inwestorzy)DANE ŹRÓDŁOWEMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., Commodore-Mensah, Y., Currie, M. E., Elkind, M. S. V., Fan, W., Generoso, G., Gibbs, B. B., Heard, D.

More news about: Amgen


Jul 30, 2026, 08:00 ET Ramaco Resources, Inc. to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 and Host Conference Call and Webcast on Wednesday, August 5

5, 2026, Ramaco Resources will host an investor conference call and webcast where Randall W. Atkins, Chairman and Chief Executive Officer, Christopher L. Blanchard, EVP for Mine Planning & Development, Jeremy R. Sussman, EVP & Chief Financial Officer, Jason T. Fannin, EVP & Chief Commercial

More news about: Ramaco Resources, Inc.


Jul 30, 2026, 08:00 ET Curis Doses First Five Patients in TakeAim CLL Study

patients with CLL (CA-4948-203, NCT07271667). Participants in the study must be in a partial response (PR) or partial response with lymphocytosis (PR-L), with measurable residual disease (MRD+) as determined by the clonoSEQ assay and actively taking zanubrutinib for at least 12 months.About

More news about: Curis, Inc.


Jul 30, 2026, 08:00 ET Federal Signal Reports Record Second Quarter Results Including 19% Net Sales Growth, 21% Operating Income Improvement, Strong Cash Generation, and 18% Increase in Orders; Raises Full-Year Outlook

in orders, gross margin expansion, and a 60-basis point increase in adjusted EBITDA margin during a record-setting second quarter," commented Jennifer L. Sherman, President and Chief Executive Officer. "These results underscore the resilience and durability of our business model, the momentum behind our

More news about: Federal Signal Corporation


Jul 30, 2026, 07:05 ET Mojo® Energy Pouches Expands Portfolio with the Launch of 100mg Caffeine Pouches and Four New Flavors

available for $32.50.Proudly Manufactured in the USA using premium US & imported ingredients, each pouch contains B-Vitamins (B3, B6, B12), L-Theanine, and adaptogens like Ginseng and Yerba Mate, and packaging can be recyclable. To use, simply pop a pouch into your mouth, enjoy for about 20 minutes,

More news about: Mojo Energy Pouches


Jul 30, 2026, 07:04 ET New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow

like unboxing a new surprise every day. My fine lines and wrinkles look reduced, while my skin feels more elastic and looks brighter.*"— Lucy L.Supporting Healthy Skin from Within*Glow features a science-backed formula with Damasty®†—which includes rose extract,

More news about: USANA


Jul 30, 2026, 07:02 ET 1911 Gold Reports High-Grade Intercepts from Near-Mine Targets at True North, Including the New Baker Target

confirmed high-grade gold mineralization from surface, hosted within the San Antonio gabbro unit (the "SAM gabbro"), on the intersection of the L10 shear zone. The historical San Antonio mine is located in the same geological setting approximately 500 m to the north. Eight (8) surface drill holes

More news about: 1911 Gold Corporation


Jul 30, 2026, 07:00 ET AAON Increases Board Size and Appoints Robert L. Buttermore III, and Patrick J. Jermain as Independent Directors

leader in high-performing, energy-efficient HVAC solutions that bring long-term value to customers and owners, today announced the appointment of Robert L. Buttermore III, and Patrick J. Jermain to its Board of Directors, effective July 28, 2026. AAON also announced that Mr. Buttermore will serve on the

More news about: AAON


Jul 30, 2026, 07:00 ET International Paper Reports Second Quarter 2026 Results

Cabourg (France), Ovar (Portugal) and Bilbao (Spain) to satisfy regulatory commitments in connection with the DS Smith combination. See notes (d) and (l) of the Consolidated Statement of Operations.(d)

More news about: International Paper


Jul 30, 2026, 06:45 ET RPC, Inc. Reports Second Quarter 2026 Financial Results And Declares Regular Quarterly Cash Dividend

Investor Relations(404) [email protected] Michael L. Schmit,Chief Financial Officer(404) [email protected]

More news about: RPC, Inc.


Jul 30, 2026, 06:45 ET Life Time Reports Second Quarter 2026 Financial Results

healthy, happy lives through its 195 athletic country clubs across the U.S. and Canada, the complementary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 25 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers

More news about: Life Time Group Holdings, Inc.


Jul 30, 2026, 06:36 ET Northeast Indiana Ranks #11 Nationally for Aerospace & Defense Manufacturing Competitiveness

workers in the country, anchored by more than 10,000 regional aerospace and defense professionals. Tier-one defense contractors including BAE Systems, L3Harris, and Raytheon operate alongside hundreds of specialized precision machining, microelectronics, and advanced composite suppliers — a supply chain that's

More news about: Northeast Indiana Regional Partnership (NEI)


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.